Here are the top stories from the last week:

Industry Updates

Surescripts survey: pharmacists, prescribers are frustrated with prior authorization
Despite these challenges, there is optimism about using technology to improve access to timely treatment. The survey underscores the need for innovation to address these administrative burdens.
Read article »

Study Reveals Why Some Children Still Have Asthma Attacks Even With Treatment
New research uncovers complex inflammatory pathways driving asthma flare-ups in children, highlighting the need for personalized treatment strategies.
Read article »

APhA Foundation Project IMPACT: Test and Treat manuscript now available
The article discusses Project IMPACT: Test and Treat, where 15 community pharmacies provided test and treat services for COVID-19, strep, and flu.
Read article »

Two-thirds of drug production facilities in disaster zones, ACS finds
A study by ACS reveals that climate disasters have affected nearly two-thirds of U.S. drug manufacturing sites, raising concerns about medication shortages.
Read article »

AAP guidance breaks with federal policy on COVID-19 vaccination for kids
The article discusses the AAP's guidance on COVID-19 vaccination for children, which differs from the CDC's current stance.
Read article »

Canada authorizes Ozempic for kidney and heart protection in diabetes
Health Canada has approved Ozempic for kidney and heart protection in type 2 diabetes, marking a significant approval.
Read article »

Pharmacy Orgs Urge Court to Uphold Tennessee's Right to Regulate PBMs
The law aims to prevent PBMs from engaging in practices like patient steering and excluding pharmacies from preferred networks. The case is currently before the federal Sixth District Court of Appeals.
Read article »

JCPP releases the 2025 Pharmacists' Patient Care Process
The Joint Commission of Pharmacy Practitioners (JCPP) has released an updated version of the Pharmacists' Patient Care Process. This update reflects contemporary practices and trends in healthcare, providing a framework for pharmacists to deliver person-centered care across various settings.
Read article »

Drug & Treatment Updates

Lupin rolls out generic Tracleer
Lupin has introduced bosentan tablets for oral suspension, a generic version of Tracleer, in the U.S. This medication is used to treat pulmonary arterial hypertension in pediatric patients. The launch follows FDA approval and grants Lupin's partner, NATCO, a 180-day exclusivity period.
Read article »

MedImpact offering low cost Stelara biosimilar to specialty pharmacies
MedImpact Holdings plans to offer a low-cost, unbranded biosimilar of Stelara, distributed by Anda, to specialty pharmacies. This strategy aims to bypass traditional supply chain costs, offering greater value and affordability to pharmacies and patients. The biosimilar will be available for purchase starting January 1, 2026.
Read article »

Elevated High-Density Lipoprotein Cholesterol May Reduce Risk of Stress Urinary Incontinence
High-density lipoprotein cholesterol, known for protective cardiovascular effects, could play a role in reducing the risk of stress urinary incontinence.
Read article »

Orforglipron Shows Positive Efficacy, Tolerability in Weight Management
The oral glucagon-like peptide agonist-1 met its primary end point and all secondary end points in a randomized, double-blind, placebo-controlled clinical trial for weight management.
Read article »

FDA Approves Donidalorsen as First RNA-Targeted Prophylactic Treatment for Hereditary Angioedema
The FDA approves donidalorsen, the first RNA-targeted therapy for hereditary angioedema, offering significant attack reduction and convenient administration.
Read article »

‍